Fig. 7From: Diosmetin inhibits cell proliferation and promotes apoptosis through STAT3/c-Myc signaling pathway in human osteosarcoma cellsSchematic illustration of the anti-tumor activity of Diosmetin on human osteosarcoma cells by inhibiting the activity of STAT3/c-MYC signaling. Persistent STAT3 activation resulting from the activation of upstream growth factor receptors (including IL-6 receptor), leads to abnormal proliferation and tumorigenesis in human osteosarcoma cells. Diosmetin inhibits cell proliferation and promotes apoptosis through STAT3/c-Myc signaling pathway in human osteosarcoma cellsBack to article page